Chief Scientific Officer
TargetRWE
Durham, United States
Jennifer Briley Christian, PharmD, PhD, FISPE is Chief Scientific Officer at TargetRWE, where she evaluates and sets priorities for the organization while providing scientific oversight and leadership to the Epidemiology and Statistics teams that are selling and delivering epidemiology and drug safety studies, causal inference software, and advanced methods such as negative control outcomes studies and clone censor weighting. She engages in many activities that are advancing the use of RWE for regulatory and payer decision-making through the National Academy of Medicine, Duke Margolis Methods Working Group, Friends of Cancer Research, and previously helped to establish the RWE Alliance trade organization.
Christian has published and edited numerous articles, including editor of “Increasing Focus on the Patient in Patient Registries” e-book published by AHRQ, contributions to the first textbook on pragmatic trials, Pragmatic Randomized Clinical Trials, and author on the National Academy of Medicines’ paper, “Generating Knowledge from Best Care: Advancing the Continuously Learning Health System”. Christian is an Anniversary Fellow at the National Academy of Medicine, a PCORI Clinical Trials Advisory Panel, and an adjunct faculty member within the Division of Clinical Epidemiology and Evaluative Sciences Research at Weill Cornell Medical College. She is a Fellow, former board member, and currently VP of Finance Elect of the International Society of Pharmacoepidemiology (ISPE).
Disclosure information not submitted.
Methods and New Approaches in Pragmatic Trials
Wednesday, August 23, 2023
2:00 PM – 6:00 PM ADT
